
Retinal AI imaging may predict CVD risk; in CLAiR, ~1 in 4 met lipid-lowering criteria
Louis highlights that cheap, quick eye imaging analyzed by AI could estimate cardiovascular risk. In the CLAiR randomized trial, almost a quarter of patients without heart disease met guideline thresholds for lipid lowering based on a 7.5% 10-year ASCVD risk target.







